Letter Sequence Other |
|---|
EPID:L-2017-PMP-0014, Shine Medical Technologies, Inc., Submittal of Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 (Open) |
Initiation
- Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request
- Acceptance...
Results
Other: ML18054A077, ML18087A340, ML18127B706, ML18128A034, ML18155A603, ML18162A117, ML18162A118, ML18162A129, ML18193A141, ML18268A344, ML18340A171, ML18340A276, ML19015A352, ML19071A185
|
MONTHYEARML18030A7422017-07-14014 July 2017
Irrevocable Standby Letter of Credit (Redacted)
Project stage: Request
ML18054A0772018-03-0808 March 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18092A0872018-03-27027 March 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Request
ML18087A3892018-03-28028 March 2018
Meeting Slides for the April 3, 2018, Public Meeting Between Shine Medical Technologies. Inc. and the NRC
Project stage: Request
ML18162A0542018-03-28028 March 2018, 29 March 2018, 3 April 2018, 18 June 2018
Shine Medical Technologies, Inc. April 3, 2018 Public Meeting
Project stage: Request
ML18096A6882018-04-0303 April 2018
Confirmatory Action Letter (CAL) No. NRR-2011-001
Project stage: Request
ML18096A4552018-04-0303 April 2018
Shine Operating License Pre-Application Meeting (Environmental Presentation Slides)
Project stage: Request
ML18087A3402018-04-0303 April 2018
Response to Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18096A6892018-04-0303 April 2018
Arrr Restart Plan (4/3/2018) Approach to Critical, Control Rod and Power Calibrations
Project stage: Request
ML18130A5782018-05-0707 May 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Request
ML18162A1362018-05-11011 May 2018, 18 June 2018
Shine Medical Technologies, Inc. May 23, 2018 Public Meeting
Project stage: Request
ML18138A2912018-05-16016 May 2018
Shine Medical Technologies, Inc. - Submittal of Meeting Slides for the May 23 and 24, 2018 with NRC
Project stage: Request
ML18128A0342018-05-16016 May 2018
Response to Second Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18156A1302018-06-0101 June 2018
Inc. - Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Request
ML18155A6032018-06-0707 June 2018
Response to Third Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18162A1172018-06-18018 June 2018
Shine Medical Technologies Acknowledgment of Receipt of 2016 Annual Financial Report
Project stage: Other
ML18162A0552018-06-18018 June 2018
Shine Medical Technologies April 3, 2018 Public Meeting Summary
Project stage: Meeting
ML18162A1162018-06-18018 June 2018
Shine Medical Technologies Annual Financial Report
Project stage: Request
ML18162A1182018-06-18018 June 2018
Shine Medical Technologies Response to Request for Withholding Letter for 2016 Annual Financial Report
Project stage: Other
ML18162A1292018-06-18018 June 2018
Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Periodic Reports on Construction Permit Conditions
Project stage: Other
ML18162A1382018-06-18018 June 2018
May 23-24, 2018, Summary of Meeting with Shine Medical Technologies, Inc
Project stage: Meeting
ML18127B7062018-06-21021 June 2018
Closure of NRC Confirmatory Action Letter No. NRR-2011-001
Project stage: Other
ML18221A4532018-06-27027 June 2018, 17 August 2018
Shine Medical Technologies, Inc. June 2018 Public Meeting
Project stage: Request
ML18187A2162018-07-0202 July 2018
Resubmittal of Meeting Slides for the June 28, 2018, Public Meeting Between Shine Medical Technologies, Inc. and the NRC
Project stage: Request
ML18197A0802018-07-10010 July 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Request
ML18193A1412018-07-16016 July 2018
Response to Fourth Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML18277A1962018-07-17017 July 2018
Amendment to Standby Letter of Credit (Redacted)
Project stage: Request
ML18206A7262018-07-18018 July 2018
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor (Redacted)
Project stage: Request
ML18221A4542018-08-17017 August 2018
Summary of Meeting with Shine Medical Technologies, Inc.
Project stage: Meeting
ML18239A2192018-08-27027 August 2018
Request for Confirmation of the 10 CFR Part 140 Financial Protection Requirements for the Shine Facility
Project stage: Request
ML18268A3442018-10-0202 October 2018
Letter of Appreciation for the Tour of the Research Test Reactor Fuel Fabrication Facility Provided to the U.S. Nuclear Regulatory Commission on August 21, 2018 EPID No. L-2017-PMP-0014
Project stage: Other
ML18340A1712018-12-10010 December 2018
Shine Medical Technologies, Inc. - Acknowledgement of Receipt of Periodic Report on Construction Permit Conditions
Project stage: Other
ML18340A2762018-12-19019 December 2018
Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Request for Confirmation of Applicable Financial Protection Requirements
Project stage: Other
ML19025A2642019-01-22022 January 2019
Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC
Project stage: Request
ML19024A3522019-01-22022 January 2019
Shine Medical Technologies - Meeting Slides for the January 31, 2019 Public Meeting Between Shine Medical Technologies, Inc. and the NRC
Project stage: Request
ML19025A2752019-01-22022 January 2019
Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC
Project stage: Request
ML19015A3522019-02-15015 February 2019
Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor
Project stage: Other
ML19071A1852019-03-22022 March 2019
Shine Medical Technologies, Inc. - Request for Withholding from Public Disclosure
Project stage: Other
ML19071A1812019-03-22022 March 2019
Shine Medical Technologies, Inc. - January 31, 2019 Public Meeting Summary
Project stage: Meeting
ML19071A1792019-03-22022 March 2019
Shine Medical Technologies, Inc. January 31, 2019 Public Meeting
Project stage: Request
ML19071A1802019-03-22022 March 2019
Shine Medical Technologies, Inc. - Request for Withholding Information from Public Disclosure
Project stage: Withholding Request Acceptance
2018-06-18
[Table View] |
|
|---|
Category:Letter
MONTHYEARML24024A1502024-01-25025 January 2024
BWXT Nuclear Operations Group, Inc. Integrated Inspection Report 07000027/2023004
ML24019A1492024-01-24024 January 2024
BWXT Nuclear Operations Group, Inc. -Lynchburg, U.S. NRC Inspection Report 0700027/2022006 and Notice of Violation
ML24016A1912024-01-17017 January 2024
TRISO-X - U.S. Nuclear Regulatory Commission Inspection Report 07007027/2023006
ML23325A0402023-11-16016 November 2023
BWXT Nuclear Operations Group, Inc - Lynchburg'S (BWXT NOG-L) - 30 Day Written Report of Event Notification EN-56768
ML23325A0382023-11-16016 November 2023
BWXT Nuclear Operations Group, Inc. - Lynchburg, Request for Exemption from Security Event Notification and Suspicious Activity Reporting Implementation in Accordance with 10 CFR 73.5
ML23292A1252023-10-25025 October 2023
BWXT Nuclear Operations Group, Inc. - Integrated Inspection Report 07000027/2023003
ML23269A0242023-09-26026 September 2023
BWXT Nuclear Operations Group, Inc. - Material Control and Accounting Program Inspection Report 07000027/2023402 (Cover Letter)
ML23253A0012023-09-15015 September 2023
BWXT NOG-L - Physical Security Core Inspection Report 07000027/2023405 - Cover
ML23256A0092023-09-14014 September 2023
BWXT Nuclear Operations Group, Inc. Lynchburg Inspection Schedule for Calendar Year 2024
ML23257A2052023-09-0606 September 2023
Bwx Technologies, Inc. Submittal of Revision 1 to Chapter 1, General Information and Chapter 2, Organization & Administration, of License SNM-42 License Application - Redacted Cover Letter
ML23248A3072023-09-0505 September 2023
Lynchburg Technology Center - Physical Security Core Inspection Report 07000027/2023406
ML23243A8582023-09-0101 September 2023
License Amendment 46 Approval of Physical Protection Plan, Revision 27 (Enterprise Project Identifier L-2023-SPR-0000)
ML23209A8272023-08-24024 August 2023
BWXT Nuclear Operations Group, Inc. - Lynchburg - Notice of Violation and Proposed Imposition of Civil Penalty - $87,500; NRC Inspection Report No. 07000027/2023007
ML23241A0432023-08-24024 August 2023
Bwx Technologies, Inc., Semi-Annual Effluent Monitoring Report for First Half of 2023
ML23171A9282023-06-12012 June 2023
BWXT Nuclear Operations Group, Inc., Submittal of Emergency Plan, Revision 36
ML23171A9302023-06-12012 June 2023
BWXT Nuclear Operations Group, Inc., Submittal of Mt. Athos Site Emergency Plan, Revision 36
ML23115A0202023-05-0505 May 2023
BWXT Nuclear Operations Group, Inc., - Lynchburg - NRC Inspection Report 07000027/2023006 and Apparent Violations
ML23116A0862023-04-27027 April 2023
BWXT Nuclear Operations Group, Inc. Integrated Inspection Report 07000027/2023001
ML23108A3262023-04-25025 April 2023
Cover Letter - BWXT Amendment 45
ML23100A0532023-04-0606 April 2023
BWXT Nuclear Operations Group - Lynchburg - Physical Security Core Inspection Report 07000027 2023403 Cover Letter
ML23096A2252023-04-0404 April 2023
BWXT Nuclear Operations Group, Inc., Submittal of 60-Day Written Report for Event Notification Number EN-56336
ML23212A9182023-04-0404 April 2023
BWXT EN 56336 60 Day Report_Redacted
ML23089A3842023-03-31031 March 2023
BWXT Nuclear Operations Group, Inc - Material Control and Accounting Program Inspection Report 07000027/2023401
ML23060A1122023-03-0606 March 2023
BWXT Nuclear Operations Group, Inc. - Licensee Performance Review (Nuclear Regulatory Commission Inspection Report 07000027/2023005)
ML23059A2802023-02-23023 February 2023
BWXT Nuclear Operations Group, Inc. Submittal of Lynchburg Facility Semi-Annual Effluent Report for 2022
ML23046A0872023-02-0909 February 2023
BWXT Nuclear Operations Group- Lynchburg, Inc., Fatigue Management Program Annual Data Report
ML23025A0912023-01-30030 January 2023
BWXT Nuclear Operations Group, Inc. Integrated Inspection Report 07000027/2022004
ML22341A2132022-12-15015 December 2022
Letter - BWXT Amendment 44
ML22340A5982022-11-30030 November 2022
11-30-2022 Letter from BWXT NOG-L: Request to Amend License SNM-42 in Accordance with the Revised Fundamental Nuclear Material Control Plan (FNMCP)
ML22318A2632022-11-14014 November 2022
BWXT-NOG L Physical Security Core Inspection Report 07000027/2022405 (Cover Letter)
ML22297A1342022-10-27027 October 2022
BWXT Nuclear Operations Group, Inc. - Integrated Inspection Report 07000027/2022003
ML22297A2082022-10-25025 October 2022
BWXT Nuclear Operations Group - Lynchburg Material Control and Accounting Program Inspection Report 07000027 2022403 Cover Letter
ML23075A1782022-10-0505 October 2022
22-061 BWXT Information to Be Withheld from the Pec, Submitted Under 10 CFR 2..390(b)(1) Letter Unsecured for ADAMS Redacted (Dated - 10-5-2022)
ML22263A0442022-09-15015 September 2022
BWXT Nuclear Operations Group, Inc., Emergency Plan Revision 35
ML23075A1642022-09-0101 September 2022
BWXT Technologies Request for Closed Predecisional Enforcement Conference (Dated 9-1-2022) Unsecured for ADAMS
ML22235A7222022-08-18018 August 2022
BWXT Nuclear Operations Group, Inc. - Lynchburg, Semi-Annual Effluent Monitoring Report
ML22224A1782022-08-0505 August 2022
BWXT Nuclear Operations Group, Inc. - Lynchburg, Updated Financial Assurance Documents, Certification of Financial Assurance and Revised SNM-42 License Application, Chapter 10, Decommissioning
ML22207B2302022-07-26026 July 2022
BWXT Nuclear Operations Group, Inc. - Lynchburg - Integrated Inspection Report 07000027/2022002
ML22153A5122022-07-12012 July 2022
BWXT Nuclear Operation Group, Inc. - Interim Approval of Chapter 10, Decommissioning (Enterprise Project Identifier L-2021-DFA-0010)
ML22187A1872022-07-0606 July 2022
BWXT Nuclear Operations Group, Inc., Lynchburg - Inspection Schedule for Calendar Year 2023
ML22182A4832022-06-24024 June 2022
BWXT Nuclear Operations Group, Inc., Response to Request for Additional Information - Decommissioning Cost Updates
ML22123A0502022-06-0606 June 2022
BWXT Nuclear Operations Group, Inc. - Lynchburg NRC Inspection Report No. 07000027/2021006 and Apparent Violations
ML22151A0272022-05-18018 May 2022
BWXT Nog 60-Day Written Report Per 10 CFR 71.95(c)
ML22143A8942022-05-18018 May 2022
Bwx Technologies, Inc., 60-Day Written Report - 16 CFR 71.~5(c)
2024-01-25
[Table view] |
Text
October 2, 2018 Mr. B. Joel Burch, Vice President and General Manager BWXT Nuclear Operations Group, Inc.
P.O. Box 785 Lynchburg, VA 24505-0785
SUBJECT:
LETTER OF APPRECIATION FOR THE TOUR OF THE RESEARCH TEST REACTOR FUEL FABRICATION FACILITY PROVIDED TO THE U.S. NUCLEAR REGULATORY COMMISSION ON AUGUST 21, 2018 (EPID NO. L-2017-PMP-0014)
Dear Mr. Burch:
On August 21, 2018, 13 members of the U.S. Nuclear Regulatory Commission (NRC) Division of Licensing Projects, Research and Test Reactors Oversight Branch, and Research and Test Reactors Licensing Branch staff, participated in a tour of the BWXT Research Test Reactor Fuel Fabrication Facility in Lynchburg, Virginia. The purpose of the tour was to gain insights into both the existing research reactor plate fuel production process, as well as the fuel development work being conducted in conjunction with the U.S. Department of Energy, Office of Material Management and Minimization, High Performance Research Reactor Conversion project.
The NRC staff gained important technical insights on this tour, and will be better informed with respect to future licensing actions involving research reactor fuel. Furthermore, the NRC staff recognized the level of effort expended by BWXT to provide this tour, and wish to express its appreciation to your staff: Mr. Van Mauney, Mr. David Miller, Mr. Scott Niedzialek, Mr. Chris Terry, Mr. Stephen Subosits, and Ms. Sandra Rice, and other BWXT staff, who provided both technical tour information as well as coordinated itinerary, schedule, and site access support.
If you have any questions, please contact Mr. Geoffrey Wertz at 301-415-0893, or by electronic mail to Geoffrey.Wertz@nrc.gov.
Sincerely,
/RA/
Mary Jane Ross-Lee, Deputy Division Director Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 70-27 License No. SNM-42
ML18268A344 *concurrence via email OFFICE NRR/DLP/PRLB/PM* NRR/DLP/PRLB/LA* NRR/DLP/PRLB/BC NRR/DLP/DD NAME GWertz NParker AAdams MJRoss-Lee DATE 9/26/2018 9/26/2018 10/1/2018 10/2/2018